Up to now all the prospective GPR119 agonists were plagued by low bioavailability, lack of efficacy and more importantly, cardiotoxicity which has stopped all human studies before any large scale Phase III clinical trials (239)
Manufactured in a facility that processes milk, soya, and nuts
331, 1st Floor, Phase -1, Industrial Area, Panchkula, Haryana, 134113, India glutathione injection in Panchkula Report incorrect details
Kuzmicic J, Parra V, Verdejo HE, Lopez-Crisosto C, Chiong M, Garcia L, et al
It is important to consult with your healthcare provider as self-administration without professional guidance is strictly forbidden